Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling

Sadanori Furudate; Taku Fujimura; Yumi Kambayashi; Takanori Hidaka; Yota Sato; Kayo Tanita; Akira Hashimoto; Setsuya Aiba

doi:10.1111/1346-8138.13898

Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling

Sadanori Furudate, Taku Fujimura, Yumi Kambayashi, Takanori Hidaka, Yota Sato, Kayo Tanita, Akira Hashimoto, Setsuya Aiba

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	e226-e227
Journal	Journal of Dermatology
Volume	44
Issue number	9
DOIs	https://doi.org/10.1111/1346-8138.13898
Publication status	Published - 2017 Sept

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/1346-8138.13898

Cite this

Furudate, S., Fujimura, T., Kambayashi, Y., Hidaka, T., Sato, Y., Tanita, K., Hashimoto, A., & Aiba, S. (2017). Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling. Journal of Dermatology, 44(9), e226-e227. https://doi.org/10.1111/1346-8138.13898

Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling. / Furudate, Sadanori ; Fujimura, Taku ; Kambayashi, Yumi et al.
In: Journal of Dermatology, Vol. 44, No. 9, 09.2017, p. e226-e227.

Research output: Contribution to journal › Letter › peer-review

Furudate, S , Fujimura, T , Kambayashi, Y , Hidaka, T, Sato, Y, Tanita, K, Hashimoto, A & Aiba, S 2017, 'Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling', Journal of Dermatology, vol. 44, no. 9, pp. e226-e227. https://doi.org/10.1111/1346-8138.13898

@article{0cc8948d017c47c38a071dd6937049b6,

title = "Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling",

author = "Sadanori Furudate and Taku Fujimura and Yumi Kambayashi and Takanori Hidaka and Yota Sato and Kayo Tanita and Akira Hashimoto and Setsuya Aiba",

year = "2017",

month = sep,

doi = "10.1111/1346-8138.13898",

language = "English",

volume = "44",

pages = "e226--e227",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling

AU - Furudate, Sadanori

AU - Fujimura, Taku

AU - Kambayashi, Yumi

AU - Hidaka, Takanori

AU - Sato, Yota

AU - Tanita, Kayo

AU - Hashimoto, Akira

AU - Aiba, Setsuya

PY - 2017/9

Y1 - 2017/9

UR - http://www.scopus.com/inward/record.url?scp=85018798269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018798269&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.13898

DO - 10.1111/1346-8138.13898

M3 - Letter

C2 - 28439948

AN - SCOPUS:85018798269

SN - 0385-2407

VL - 44

SP - e226-e227

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 9

ER -

Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this